Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Prepaid Assets (2016 - 2026)

Ovid Therapeutics filings provide 11 years of Prepaid Assets readings, the most recent being $4.6 million for Q1 2026.

  • Quarterly Prepaid Assets rose 58.05% to $4.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.6 million through Mar 2026, up 58.05% year-over-year, with the annual reading at $4.7 million for FY2025, 65.2% up from the prior year.
  • Prepaid Assets hit $4.6 million in Q1 2026 for Ovid Therapeutics, down from $4.7 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $5.7 million in Q2 2023 and bottomed at $1.8 million in Q1 2023.
  • Average Prepaid Assets over 5 years is $3.4 million, with a median of $3.1 million recorded in 2024.
  • The largest annual shift saw Prepaid Assets surged 108.22% in 2023 before it crashed 32.89% in 2024.
  • Ovid Therapeutics' Prepaid Assets stood at $2.4 million in 2022, then surged by 58.16% to $3.8 million in 2023, then fell by 23.86% to $2.9 million in 2024, then surged by 65.2% to $4.7 million in 2025, then dropped by 2.32% to $4.6 million in 2026.
  • Per Business Quant, the three most recent readings for OVID's Prepaid Assets are $4.6 million (Q1 2026), $4.7 million (Q4 2025), and $3.2 million (Q3 2025).